Clinical Trials Browser

Phase 3 × Lymphoma, Follicular × eicosapentaenoic acid ethyl ester × Clear all

NCT00146211 2007-12-27

TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease

Phase 3 Completed

Huntington Disease, Lymphoma, Follicular